Adalimumab monotherapy versus combination therapy with immunomodulators in patients with Crohn's disease: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adalimumab monotherapy versus combination therapy with immunomodulators in patients with Crohn's disease: A systematic review and meta-analysis

Published:2014-12 Issue:12 Volume:8 Page:1632-1641
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:Journal of Crohn's and Colitis

Author:

Kopylov Uri,Al-Taweel Talal,Yaghoobi Mohammad,Nauche Benedicte,Bitton Alain,Lakatos Peter L.,Ben-Horin Shomron,Afif Waqqas,Seidman Ernest G.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Reference55 articles.

1. Adalimumab and infliximab are equally effective for Crohn's disease in patients not previously treated with anti-tumor necrosis factor-α agents;Kestens;Clin Gastroenterol Hepatol,2013

2. Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial;Hanauer;Lancet,2002

3. Infliximab maintenance therapy for fistulizing Crohn's disease;Sands;N Engl J Med,2004

4. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease;Rutgeerts;Gastroenterology,1999

5. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial;Colombel;Gastroenterology,2007

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 6‐Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy;Internal Medicine Journal;2024-09-05

2. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

3. ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment;Journal of Crohn's and Colitis;2024-06-15

4. Controversies in the management of anti-TNF therapy in patients with Crohn’s disease: a Delphi consensus;BMJ Open Gastroenterology;2024-01

5. Personalized Treatment for Crohn’s Disease: Current Approaches and Future Directions;Clinical and Experimental Gastroenterology;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3